Qiagen (QGEN) Other Non-Current Liabilities (2009 - 2026)
Qiagen (QGEN) posted Other Non-Current Liabilities of $336.5 million for Q4 2025, up 11.03% sequentially from $303.1 million in Q3 2025, and up 39.87% YoY from $240.6 million in Q4 2024.
Qiagen (QGEN) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
Qiagen has reported Other Non-Current Liabilities for 17 years, with the latest figure at $336.5 million in Q4 2025.
- Quarterly Other Non-Current Liabilities rose 39.87% year-over-year to $336.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $336.5 million (up 39.87% YoY) and the FY2025 annual result came in at $336.5 million, up 39.87% from the prior year.
- Other Non-Current Liabilities advanced to $336.5 million in Q4 2025 per QGEN's latest filing, from $303.1 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $336.5 million in Q4 2025 and troughed at $156.7 million in Q4 2022.
- A 5-year average of $225.5 million and a median of $212.7 million in 2023 frame the typical range for Other Non-Current Liabilities.
- The widest YoY moves for Other Non-Current Liabilities: up 87.62% in 2021, down 37.25% in 2021.
- Over 5 years, Other Non-Current Liabilities stood at $246.9 million in 2021, then plunged by 36.53% to $156.7 million in 2022, then soared by 32.34% to $207.4 million in 2023, then climbed by 16.0% to $240.6 million in 2024, then soared by 39.87% to $336.5 million in 2025.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $336.5 million, $303.1 million, and $305.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Qiagen | 8.65 Bn | 8.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.30 Mn |
| Dec 31, 2025 | 336.51 Mn |
| Sep 30, 2025 | 303.09 Mn |
| Jun 30, 2025 | 305.11 Mn |
| Mar 31, 2025 | 267.90 Mn |
| Dec 31, 2024 | 240.59 Mn |
| Sep 30, 2024 | 247.05 Mn |
| Jun 30, 2024 | 235.55 Mn |
| Mar 31, 2024 | 212.64 Mn |
| Dec 31, 2023 | 207.40 Mn |
| Sep 30, 2023 | 204.66 Mn |
| Jun 30, 2023 | 212.74 Mn |
| Mar 31, 2023 | 221.81 Mn |
| Dec 31, 2022 | 156.72 Mn |
| Sep 30, 2022 | 169.20 Mn |
| Jun 30, 2022 | 175.35 Mn |
| Mar 31, 2022 | 200.81 Mn |
| Dec 31, 2021 | 246.91 Mn |
| Sep 30, 2021 | 196.73 Mn |
| Jun 30, 2021 | 189.29 Mn |